Development and validation of a novel N6-methyladenosine (m6A)-related multi- long non-coding RNA (lncRNA) prognostic signature in pancreatic adenocarcinoma

Development and validation of a novel N6-methyladenosine (m6A)-related multi- long non-coding RNA (lncRNA) prognostic signature in pancreatic adenocarcinoma

Accumulating evidence has unveiled the pivotal roles of N6-methyladenosine (m6A) in pancreatic adenocarcinoma (PAAD). However, there are not many researches to predict the prognosis of PAAD using m6A-related long non-coding RNAs (lncRNAs). Raw data from The Cancer Genome Atlas (TCGA), International...

Full description

Bibliographic Details
Main Authors: Qihang Yuan, Jie Ren, Lunxu Li, Shuang Li, Kailai Xiang, Dong Shang
Format: Article
Language:English
Published: Taylor & Francis Group 2021-01-01
Series:Bioengineered
Subjects:
pancreatic adenocarcinoma
n6-methyladenosine
long non-coding rnas
prognostic signature
bioinformatics
Online Access:http://dx.doi.org/10.1080/21655979.2021.1933868

Internet

http://dx.doi.org/10.1080/21655979.2021.1933868

Similar Items